Anne Hertenstein

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation

Felix Sahm, Ahmed Sadik, Damian Stichel et al. · Neuro-Oncology · 2017 · 74 citations · Full text

Medicine, Molecular Biology, Oncology +17

Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of<i>IDH</i>Mutation Status and Tumor Progression

Armin Biller, Stephanie Badde, Armin M. Nagel et al. · American Journal of Neuroradiology · 2015 · 70 citations · Full text

Medicine, Oncology, Radiology +17

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma

Felix Sahm, Jonas Blaes, Matthias Osswald et al. · Oncotarget · 2015 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +17

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma

Sina Burth, Philipp Kickingereder, Oliver Eidel et al. · Neuro-Oncology · 2016 · 47 citations · Full text

Medicine, Oncology, Radiology +17

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy

Dieter Lemke, Hans-Werner Pledl, Markus Zorn et al. · Oncotarget · 2016 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17